Sharon Townson
Net worth: 1 M $ as of 31/05/2026
Net worth: 1 M $ as of 31/05/2026
Dr. Sharon Townson is a Chief Scientific Officer at Monte Rosa Therapeutics, Inc. Dr. Townson was previously employed as an Executive Director & Head-Platform Biology by Kymera Therapeutics, Inc. and a Scientific Director-Physical Biochemistry by Warp Drive Bio, Inc. She received her undergraduate degree from the University of Salford and a doctorate degree from the University of Manchester Institute of Science & Technology.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/06/2026 | 67,845 ( 0.08% ) | 1 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| Companies | Position | End |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 01/06/2020 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Corporate Officer/Principal | 01/12/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Salford
University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions